9th Annual microRNA: Targets and Tools for Therapeutic Development
Venue: Marriott Cambridge
|Event Date/Time: Mar 04, 2013||End Date/Time: Mar 05, 2013|
|Registration Date: Mar 04, 2013|
|Early Registration Date: Dec 07, 2012|
microRNAs are playing an important role in a range of diseases, such as cancer, metabolic diseases and cardiovascular disorders. Their involvement in many physiological pathways makes them an excellent target for pharmaceutical drug development and their use as biomarkers for profiling and screening turns them into a valuable tool for diagnostics.
Join your peers for a program on the latest developments in using miRNAs for health and disease, the novel applications made in manipulating microRNAs, and the opportunities for using microRNA as a tool.
The meeting features a world-class speaker lineup, including representatives from Hoffman-La Roche, Novartis, SomaGenics and Yale School of Medicine.
Topics to be covered include:
- miRNA as a diagnostic tool
- miRNA targets for drug development
- miRNA identification and profiling approaches
- miRNA as biomarker
- miRNA as cancer therapeutics
- microRNA in the clinic
- Blood-based assays
- Novel microRNA inhibitors
View the full agenda and speaker list at www.healthtech.com/mrn
Secure your place early to save.